Detalhe da pesquisa
1.
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Nat Immunol
; 23(9): 1379-1392, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002648
2.
Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.
Int J Mol Sci
; 24(4)2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835424
3.
Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamide.
Int J Cancer
; 142(5): 976-987, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28975621
4.
IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell Killing.
Cancers (Basel)
; 11(11)2019 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31717819
5.
Gut Mesenchymal Stromal Cells in Immunity.
Stem Cells Int
; 2017: 8482326, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28337224
6.
IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils.
Oncoimmunology
; 6(6): e1317420, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28680750
7.
Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.
J Invest Dermatol
; 137(1): 159-169, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27623509
8.
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.
Nat Med
; 20(11): 1301-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344738
9.
The Janus face of cyclophosphamide: A sterile inflammatory response that potentiates cancer immunotherapy.
Oncoimmunology
; 2(9): e25789, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24244905